Three Month Efficacy/Safety Study With a 3-Month Safety Extension of Brinzolamide 1%/Brimonidine 0.2% vs. Brinzolamide 1% or Brimonidine 0.2%

Clinical trial NCT01297920 · COMPLETED

Trial details

NCT number: NCT01297920
Sponsor: Alcon Research
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Open-Angle Glaucoma Ocular Hypertension

Start date: 2011-03-01
Primary completion: 2012-06-01
Enrollment: 1062

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.